Early Intervention and Health Promotion in the Management of Chronic Liver Disease

Early Intervention and Health Promotion in the Management of Chronic Liver Disease

Shaila Hussain (King's College, London, UK)
Copyright: © 2018 |Pages: 17
DOI: 10.4018/IJUDH.2018010102
OnDemand PDF Download:
No Current Special Offers


Liver disease is prevalent and a major public health concern. It has predominantly spread in the UK and worldwide, causing liver-related morbidity and mortality rates for the under 65s since 1970. This article aims to highlight the role of early intervention and health promotion in the management of chronic liver disease (CLD). The objective is to critically analyse an issue like CLD, and further employ principles, ethical theories to health promotion practice. Since 2015, there is no one single drug that treats NALFD, a dietary plan and lifestyle modifications can be added in management of the disease. Educating patients perhaps is a form of regimen, and a coping mechanism as set by the health belief model to understand the disease. Additional studies need to be formed to understand the exact contributions health care professionals are likely to make, and of those that are new clinicians.
Article Preview

What Is Liver Disease?

Chronic liver disease (CLD) is sustained through exposure of the liver to a number of viruses, excessive alcohol consumption, excessive fat consumption, bio transformed metabolites and cholestasis causing elongated hepatic injury. Once endured, it causes CLD, arising in multistage advancements of fibrosis, cirrhosis, HCV and Hepatocellular carcinoma (HCC) (Chatterjee & Mitra 2015).

CLD characterises a few or no more symptoms that occur in the illness until it becomes credible. The predominant level of scarring of the liver tissue causes further symptoms of viral hepatitis, with a possibility of the illness being resolved. However, if the cause is liver cirrhosis, it is contemplated to be irreversible and complications may arise in progression and management of the disease (Chow & Chow 2006). Immunological impairments are at the forefront for CLD patients, infections are susceptible in this cluster of patients and are known to be secondary to other complications. Nevertheless, bacterial infections amongst end-stage CLD have high rates of bacterial peritonitis, pneumonia, urinary tract infections and sepsis (Mehta & Lyon 2010). In the entire prognosis that implements CLD, it can develop easily into chronic hepatitis that lasts around six months. Figure 1 summarises CLD forms and classifications. All types of chronic liver disease are related to vascular obstruction and various anatomic patterns that interrelate the distribution and severity in the disruptive injury (See Figure 2) (Schiff et al., 2011).

Figure 1.

Unified classification of acute chronic liver failure (Adapted from Bernal et al., 2015)


Complete Article List

Search this Journal:
Open Access Articles
Volume 8: 2 Issues (2018)
Volume 7: 2 Issues (2017)
Volume 6: 2 Issues (2016)
Volume 5: 2 Issues (2015)
Volume 4: 4 Issues (2014)
Volume 3: 4 Issues (2013)
Volume 2: 4 Issues (2012)
Volume 1: 4 Issues (2011)
View Complete Journal Contents Listing